Search - tctmd.com

Displaying 601 - 620 of 862

Sort: Relevancy | Date

News Daily News

La Intervención Invasiva Precoz es Mejor que la Demorada en el Manejo de NSTE¬MI

Michael O'Riordan

January 20, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Daily News

Muchos Supervivientes de Cáncer Infantil Presentan Patologías Cardíacas Silentes

Yael L. Maxwell

January 06, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Opinion Fellow Talk

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

Waleed Alharbi, MD

November 29, 2015

News Daily News

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Caitlin E. Cox

November 23, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

News Daily News

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

Shelley Wood

November 12, 2015

News Daily News

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

Shelley Wood

November 11, 2015

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

Advertisement

La Intervención Invasiva Precoz es Mejor que la Demorada en el Manejo de NSTE¬MI

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Muchos Supervivientes de Cáncer Infantil Presentan Patologías Cardíacas Silentes

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content